24344-58-9

Basic information

• Product Name: Stannane, tributyl(3-chlorophenyl)-
• CAS NO: 24344-58-9
• Molecular Formula: C18H31ClSn
• Molecular Weight: 401.607
• Mol File: 24344-58-9.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Stannane, tributyl(3-chlorophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Stannane, tributyl(3-chlorophenyl)-(24344-58-9)
• EPA Substance Registry System: Stannane, tributyl(3-chlorophenyl)-(24344-58-9)

Safety Data

• Hazardous Substances Data: 24344-58-9(Hazardous Substances Data)

Upstream product

• 21383-00-6 3-chlorophenyl methyl sulfone 
• 813-19-4 bis(tri-n-butyltin) 
• 15946-37-9 sodium 3-chlorobenzenesulfinate 
• 108-37-2 1-bromo-3-chlorobenzene 
• 1461-22-9 tributyltin chloride 
• 36229-42-2 (3-chlorophenyl)magnesium bromide 
• 625-99-0 3-iodochlorobenzene 

Downstream Products

• 136294-95-6 (E)-4-(3-Chloro-phenyl)-but-2-enoic acid 
• 587-04-2 m-Chlorobenzaldehyde 
• 1016-78-0 3-chlorobenzophenone 
• 84363-90-6 (1RS,2SR)-1,2-diphenyl-3-buten-1-ol 
• 32363-46-5 (3-chlorophenyl)(3-methoxyphenyl)methanone 
• 74447-83-9 3-chloro-3'-methoxy-1,1'- biphenyl 
• 5957-85-7 2-(3-chlorophenyl)pyridine 
• 21550-08-3 1-(3-chlorophenyl)butan-1-one 
• 53226-55-4 1-(3-chlorobiphenyl)-2,2-dimethylpropan-1-one 
• 26673-31-4 6-chloro-3,4-dihydronaphthalen-1(2H)-one 
• 17260-71-8 3-chloro-benzenesulfonamide 

Relevant articles and documents

Synthesis of arylstannanes by palladium-catalyzed desulfitative coupling reaction of sodium arylsulfinates with distannanes

A novel Pd-catalyzed desulfitative cross-coupling reaction of sodium arylsulfinates with hexaalkyl distannanes is realized, allowing the facile synthesis of functionalized arylstannanes with moderate to excellent yields. The successful implement of gram-scale synthesis and tandem Stille coupling reaction demonstrates the potential applications of this method in organic synthesis.

COMBINATION THERAPY OF A HIF-2-ALPHA INHIBITOR AND AN IMMUNOTHERAPEUTIC AGENT AND USES THEREOF

The present invention provides methods and pharmaceutical compositions for treating proliferative disorders. The method involves step of administering to said subject a HIF-2alpha inhibitor and an immunotherapeutic agent.

COMPOSITIONS FOR USE IN TREATING PULMONARY ARTERIAL HYPERTENSION

The present disclosure provides methods of treating pulmonary arterial hypertension (PAH) in a subject in need thereof. Compositions for use in these methods are also provided.